- Home
- ACIU vs SKIL Comparison
ACIU vs SKIL Comparison
Compare ACIU & SKIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- SKIL
- Stock Information
- Founded
- ACIU 2003
- SKIL 1998
- Country
- ACIU Switzerland
- SKIL United States
- Employees
- ACIU N/A
- SKIL N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- SKIL Computer Software: Prepackaged Software
- Sector
- ACIU Health Care
- SKIL Technology
- Exchange
- ACIU Nasdaq
- SKIL Nasdaq
- Market Cap
- ACIU 189.1M
- SKIL 166.4M
- IPO Year
- ACIU 2016
- SKIL N/A
- Fundamental
- Price
- ACIU $2.02
- SKIL $15.80
- Analyst Decision
- ACIU Strong Buy
- SKIL
- Analyst Count
- ACIU 1
- SKIL 0
- Target Price
- ACIU $12.00
- SKIL N/A
- AVG Volume (30 Days)
- ACIU 128.8K
- SKIL 75.6K
- Earning Date
- ACIU 08-05-2025
- SKIL 06-09-2025
- Dividend Yield
- ACIU N/A
- SKIL N/A
- EPS Growth
- ACIU N/A
- SKIL N/A
- EPS
- ACIU N/A
- SKIL N/A
- Revenue
- ACIU $32,014,254.00
- SKIL $527,402,000.00
- Revenue This Year
- ACIU N/A
- SKIL $3.18
- Revenue Next Year
- ACIU $533.21
- SKIL $2.50
- P/E Ratio
- ACIU N/A
- SKIL N/A
- Revenue Growth
- ACIU 91.20
- SKIL N/A
- 52 Week Low
- ACIU $1.43
- SKIL $11.01
- 52 Week High
- ACIU $4.26
- SKIL $34.43
- Technical
- Relative Strength Index (RSI)
- ACIU 57.93
- SKIL 46.63
- Support Level
- ACIU $2.01
- SKIL $13.00
- Resistance Level
- ACIU $2.19
- SKIL $18.51
- Average True Range (ATR)
- ACIU 0.14
- SKIL 1.88
- MACD
- ACIU 0.00
- SKIL -0.03
- Stochastic Oscillator
- ACIU 60.75
- SKIL 45.10
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SKIL Skillsoft Corp.
Skillsoft Corp is a leader in corporate digital learning. The company's segment includes Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experience learner platform that serves learners world-wide. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.